GOLM1 and hepatocellular carcinoma: GP73 was previously reported to be significantly elevated in multiple tumors including lung adenocarcinoma [33], seminomas [34] and renal cell cancer [35], and recent studies have shown that a significantly elevated serum GP73 level is closely associated with liver diseases, particularly HCC [36, 37].